Acute Effect of Forearm Neuromuscular Taping on Pain, Biological and Functional Variables Post-exercise.
Launched by EUROPEAN UNIVERSITY OF MADRID · May 27, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how a technique called neuromuscular taping (NMT) applied to the forearm affects pain, muscle strength, and oxygen levels in the muscles after exercise. The researchers want to see if this taping can help athletes feel better and perform better right after they work out. To do this, they will split participants into four groups: two will receive different types of NMT, one will get a version without tension (a placebo), and one will not receive any taping at all.
To be eligible for this study, participants should be healthy adults aged 18 to 30, who are active and have a normal body weight. They should not have had any recent injuries or specific health issues that could affect the results. If you join the study, you can expect to perform some exercises and then receive one of the taping treatments while the researchers monitor how it affects your grip strength and pain levels. This trial is important because it could provide valuable insights for athletes and health professionals about the potential benefits of neuromuscular taping in sports.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 30 years.
- • Both genders.
- • Body mass index between 18.50 and 23.99 kg/m².
- • No musculoskeletal disorders in the last 3 months and intact skin on the forearm.
- • No neurological or circulatory disease.
- • No additional exercise or treatment during the study.
- • No induced fatigue before the experiment.
- • Physically active individual (defined as performing at least 150-300 minutes of moderate activity or 75-150 minutes of vigorous activity per week for at least 6 months).
- Exclusion Criteria:
- • Acute soft tissue injury to the upper extremity in the past month.
- • Allergy to NMT or similar drugs.
- • History of surgical procedures on the upper extremities.
- • Functional impairment of vision or vestibular sensation.
- • Frequent use of neuromuscular taping on the upper extremities.
- • Analgesic intervention for musculoskeletal pain in the past 3 weeks.
- • Participation in a physical therapy rehabilitation program in the past 3 months.
- • Serious physical injuries that limit the ability to perform these procedures.
About European University Of Madrid
The European University of Madrid is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, the university is committed to fostering innovative healthcare solutions through rigorous scientific inquiry and collaboration. With a strong emphasis on ethical standards and patient safety, the institution actively engages in multidisciplinary studies that aim to address pressing health challenges. By leveraging its extensive network of researchers and healthcare professionals, the European University of Madrid strives to contribute significantly to the advancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported